1
/
of
1
KLOW - 80mg
KLOW - 80mg
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Quantity
Couldn't load pickup availability
KLOW is a research peptide formulation designed to promote restorative sleep, stress recovery, and natural growth hormone (GH) optimization through targeted neuroendocrine support. Typically composed of synergistic peptides such as Epithalon, CJC-1295 (No DAC), and Ipamorelin—or other sleep-regulating analogs—KLOW is engineered to mimic the body’s natural nocturnal repair processes. It is studied for its potential to enhance deep sleep, improve recovery, and support cellular rejuvenation by aligning hormone secretion with circadian rhythm patterns. KLOW is intended for research use only and is not approved for therapeutic human administration.
What Are the Effects of KLOW?
- Deep Sleep Induction & GH Release: KLOW’s peptide blend promotes increased slow-wave (deep) sleep phases and stimulates pulsatile nighttime GH release, supporting physical recovery and tissue repair.
- Cellular Repair & Regeneration: By enhancing GH and IGF-1 activity, KLOW may facilitate collagen synthesis, muscle recovery, and mitochondrial function in preclinical studies.
- Stress Reduction & Hormonal Balance: Components of KLOW, such as Epithalon or other neuropeptides, help modulate melatonin and cortisol rhythms, supporting improved stress adaptation and overall endocrine harmony.
- Anti-Aging & Longevity Support: Through its effects on cellular regeneration and circadian rhythm regulation, KLOW has been studied for its role in promoting youthful metabolic patterns and improved vitality markers.
- Metabolic Recovery & Energy Optimization: KLOW’s impact on GH/IGF-1 pathways contributes to better fat metabolism, improved energy utilization, and enhanced next-day alertness following restful sleep.
- Mood & Cognitive Stability: By influencing neurochemical balance and restorative sleep quality, KLOW may support sharper mental clarity, mood regulation, and daytime focus.
- Safety Observations: Research suggests the individual peptides in KLOW are well tolerated, with mild, transient injection-site irritation being the most common observation and no significant systemic toxicity reported in controlled research environments.
Share
